Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen

Vaccine

Volumn 16, Issue 2-3, 1998, Pages 135-141

  Hathaway, Lucy J ^a   Obeid, Obeid E ^a   Steward, Michael W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Chimeric peptides; Intranasal immunization; Protection

Indexed keywords

CHOLERA TOXIN; MEASLES VACCINE; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; MALE; MEASLES; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SALIVA; SURVIVAL;

EID: 0031986204     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)88326-0     Document Type: Article

References (19)

1. 1 Sabin, A.B. My last will and testament on rapid elimination and ultimate global eradication of poliomyelitis and measles. Pediatrics 1992, 90, 162-169.
2. 2 Malvoisin, E. and Wild, F. Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J. Virol. 1990, 64, 5160-5162.
3. 3 Obeid, O.E., Partidos, C.D., Howard, C.R. and Steward, M.W. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus. J. Virol. 1995, 69, 1420-1428.
4. 4 Mazanec, M.B., Kaetzel, C.S., Lamm, M.E., Fletcher, D. and Nedrud, J.G. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl Acad. Sci. U.S.A. 1992, 89, 6901-6905.
5. 5 Renegar, K.B. and Small, P.A. Jr Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 1991, 146, 1972-1978.
6. 6 Oien, N.L., Brideau, R.J., Walsh, E.E. and Wathen, M.W. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine 1994, 12, 731-735.
7. 7 Russell, M.W., Moldoveanu, Z., White, P.L., Sibert, G.J., Mestecky, J. and Michalek, S.M. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized i.n. with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immunol. 1996, 64, 1272-1283.
8. 8 Tamura, S., Samegai, Y., Kurata, H., Nagamine, T., Aizawa, C. and Kurata, T. Protection against influenza virus infection by vaccine inoculated i.n. with cholera toxin B subunit. Vaccine 1988, 6, 409-413.
9. 9 Tamura, S., Asanuma, H. and Tomita, T. et al. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 1083-1089.
10. 10 Hathaway, L.J., Partidos, C.D., Vohra, P. and Steward, M.W. Induction of systemic immune responses to measles virus synthetic peptides administered i.n.. Vaccine 1995, 13, 1495-1500.
11. 11 Partidos, C.D. and Steward, M.W. Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans. J. Gen. Virol. 1990, 71, 2099-2105.
12. 12 Lijana, R.C. and Williams, M.C. Tetramethylbenzidine - Ta substitute for benzidine in hemoglobin analysis. J. Lab. Clin. Med. 1979, 94, 266-276.
13. 13 Johannsson, A., Ellis, D.H., Bates, D.L., Plumb, A.M. and Stanley, C.J. Enzyme amplification for immunoassays. J. Immunol. Meth. 1986, 87, 7-11.
14. 14 Rath, S., Stanley, C.M. and Steward, M.W. An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. J. Immunol. Meth. 1988, 106, 245-249.
15. 15 Giraudon, P. and Wild, T.F. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination activity. Virology 1985, 144, 46-56.
16. 16 Steward, M.W. and Chargelegue, D. Antibody affinity: measurement and biological significance. In Handbook of Experimental Immunology (Ed. Weir, D.M.). Blackwell Scientific, Oxford, 1997, pp. 38.1-38.35.
17. 17 Baldridge, J.R. and Buchmeier, M.J. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J. Virol. 1992, 66, 4252-4257.
18. 18 Ishizaka, ST., Piacente, P., Silva, J. and Mishkin, E.M. IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies. J. Infect. Dis. 1995, 172, 1108-1111.
19. 19 Coutelier, J.-P., van der Logt, J.T.M., Heessen, F.W.A., Warnier, G. and van Snick, J. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 1987, 165, 64-69.